TCRX
#4281
TScan Therapeutics, Inc. - Common Stock
0.7 5 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
-1.32%
6 month change
-26.47%
Year Change
-58.33%
Previous Close
0.7 5
Open
0.7 5
Low
0.7 5
High
0.7 5
Volume
2
Financials
- Market Capitalization 47.63 M
- Employee 142
- Founded 2018
- CEO N/A
- Website www.tscan.com
- Headquarter Delaware, United States
- FIGI BBG00PH1N007
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1
Price to sales ratio
12.57
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4256 |  MCRB Seres Therapeutics, Inc. - Common Stock | 5.11 USD | +3.23% | +13.30% | +7.13% | -37.91% | 50.80 M USD | ||
| 4257 |  HYPD Hyperion DeFi, Inc. - Common Stock | 3.26 USD | -9.94% | -4.12% | +36.97% | -45.21% | 50.66 M USD | ||
| 4293 |  CELU Celularity Inc. - Class A Common Stock | 1.58 USD | -24.76% | +105.19% | +132.35% | -49.03% | 45.73 M USD | ||
| 4294 |  HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.94 USD | -3.09% | +10.59% | +108.89% | -27.69% | 45.68 M USD |
Frequently asked questions about TScan Therapeutics, Inc. Common Stock
What is the TScan Therapeutics, Inc. Common Stock stock price today?
The current price of TScan Therapeutics, Inc. Common Stock (TCRX) is 0.75. Over the past 24 hours, the stock has changed by 0.00%. Follow the TCRX chart for real-time price dynamics.
What is the stock ticker of TScan Therapeutics, Inc. Common Stock?
TScan Therapeutics, Inc. Common Stock trades under the ticker TCRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is TScan Therapeutics, Inc. Common Stock stock going up?
TCRX has changed by -5.06% over the last week, -1.32% over the last month, and -58.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of TScan Therapeutics, Inc. Common Stock?
TScan Therapeutics, Inc. Common Stock currently has a market capitalization of 47.63 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were TScan Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, TScan Therapeutics, Inc. Common Stock reported earnings of -0.23 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was TScan Therapeutics, Inc. Common Stock revenue for the last quarter?
TScan Therapeutics, Inc. Common Stock reported quarterly revenue of 1.05 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was TScan Therapeutics, Inc. Common Stock net income for the last quarter?
TScan Therapeutics, Inc. Common Stock reported net income of -30.36 M for the last quarter. The previous quarter showed -28.67 M, which means net income changed by -5.91%.
How many employees does TScan Therapeutics, Inc. Common Stock have?
As of the latest available data, TScan Therapeutics, Inc. Common Stock has 142 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy TScan Therapeutics, Inc. Common Stock stock?
You can buy TScan Therapeutics, Inc. Common Stock (TCRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in TScan Therapeutics, Inc. Common Stock stock?
Investing in TScan Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TCRX chart and related analysis on metatrader.com as part of your research.